We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




World's First Sensor-Enabled Ablation Catheter Designed to Treat Atrial Fibrillation

By HospiMedica International staff writers
Posted on 22 May 2023

Atrial fibrillation (AFib), the most common irregular heart rhythm condition, impacts over 37 million people worldwide, a figure projected to more than double by 2050. More...

With an additional five million cases diagnosed annually, this escalating health concern creates the need for innovative solutions for patients as well as their healthcare providers. Now, a first-of-its-kind ablation catheter designed with a unique flexible electrode tip and contact force sensing, promises shorter procedure times and improved safety for AFib treatment.

Abbott’s (Abbott Park, IL, USA) TactiFlex Ablation Catheter, Sensor Enabled, is the world's first ablation catheter with a flexible tip and contact force technology. The TactiFlex catheter is designed for use with Abbott's EnSite X EP heart mapping system, allowing physicians to view and precisely pinpoint the heart areas requiring ablation. The use of the TactiFlex catheter with the EnSite X EP System enhances visualization for physicians, thereby allowing for higher accuracy and precision, leading to safer and shorter procedures.

In contrast to other catheters available in the market, the TactiFlex catheter utilizes a laser-cut pattern tip design that flexes upon contact with the heart wall. This aids in directing fluid to the treated tissue and ensures more precise catheter positioning – providing stability that's up to twice as high in a beating heart – for consistent therapy delivery. The Abbott TactiFlex catheter demonstrated robust clinical outcomes in the TactiFlex AF IDE study, creating rapid, safe lesions to treat AFib with an acute procedural success rate surpassing 99%. The TactiFlex catheter has been granted approval for usage in Europe, Japan, Africa, and Australia, and has now also received clearance from the U.S. Food and Drug Administration (FDA).

"Abbott is leading the way in helping doctors manage common arrhythmias with the most holistic portfolio for this condition in the world," said Christopher Piorkowski, M.D., chief medical officer of Abbott's electrophysiology business. "The EnSite X EP System is unmatched in determining the exact location where ablation is required. Coupled with the TactiFlex catheter, patients can now feel even more confident that their procedure will deliver safe and effective results."

Related Links:
Abbott 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.